All Stories

  1. Pyrrolizidine Alkaloids: Chemistry, Pharmacology, Toxicology and Food Safety
  2. Toxicity and structure-activity relationship (SAR) of α,β-dehydroamino acids against human cancer cell lines
  3. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
  4. Hybrid MS/NMR methods on the prioritization of natural products: Applications in drug discovery
  5. Profiling phlorotannins from Fucus spp. of the Northern Portuguese coastline: Chemical approach by HPLC-DAD-ESI/MS n and UPLC-ESI-QTOF/MS
  6. Phlorotannin extracts from Fucales: Marine polyphenols as bioregulators engaged in inflammation-related mediators and enzymes
  7. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
  8. Further insights on tomato plant: Cytotoxic and antioxidant activity of leaf extracts in human gastric cells
  9. Synthesis and preliminary biological evaluation of new phenolic and catecholic dehydroamino acid derivatives
  10. UHPLC-MS/MS profiling of Aplysia depilans and assessment of its potential therapeutic use: Interference on iNOS expression in LPS-stimulated RAW 264.7 macrophages and caspase-mediated pro-apoptotic effect on SH-SY5Y cells
  11. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  12. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  13. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  14. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  15. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  16. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study
  17. Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study
  18. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study
  19. Toxicity of phenolipids: Protocatechuic acid alkyl esters trigger disruption of mitochondrial membrane potential and caspase activation in macrophages
  20. Anti-inflammatory properties of the stem bark from the herbal drug Vitex peduncularis Wall. ex Schauer and characterization of its polyphenolic profile
  21. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  22. Neurotoxicity of the steroidal alkaloids tomatine and tomatidine is RIP1 kinase- and caspase-independent and involves the eIF2α branch of the endoplasmic reticulum
  23. Child and Adolescent Health From 1990 to 2015
  24. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
  25. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
  26. Exploratory Studies on the in Vitro Anti-inflammatory Potential of Two Herbal Teas (Annona muricata L. and Jasminum grandiflorum L.), and Relation with Their Phenolic Composition
  27. In Vitro Anti-Inflammatory and Cytotoxic Effects of Aqueous Extracts from the Edible Sea Anemones Anemonia sulcata and Actinia equina
  28. Fatty acid patterns of the kelps Saccharina latissima, Saccorhiza polyschides and Laminaria ochroleuca: Influence of changing environmental conditions
  29. Recent Patents on Proteasome Inhibitors of Natural Origin
  30. Editorial (Thematic Issue: Modulation of Proteostasis and Proteolytic Pathways as an Anti-Cancer Strategy)
  31. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
  32. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  33. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  34. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  35. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  36. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  37. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  38. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  39. Correction to Lancet HIV 2016; 3: e361–87
  40. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  41. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
  42. 10.1016/S0140-6736(15)60692-4
  43. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  44. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  45. The Global Burden of Cancer 2013
  46. Natural products targeting the ER
  47. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  48. Cork extracts reduce UV-mediated DNA fragmentation and cell death
  49. “Omics” Technologies
  50. Nano- and Microdelivery Systems for Marine Bioactive Lipids
  51. Marine natural pigments: Chemistry, distribution and analysis
  52. Meroterpenes from Marine Invertebrates: Chemistry and Application in Cancer
  53. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  54. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  55. GC-MS Lipidomic Profiling of the Echinoderm Marthasterias glacialis and Screening for Activity Against Human Cancer and Non-Cancer Cell Lines
  56. Anti-Inflammatory Effect of Unsaturated Fatty Acids and Ergosta-7,22-dien-3-ol from Marthasterias glacialis: Prevention of CHOP-Mediated ER-Stress and NF-κB Activation
  57. Palmitic Acid and Ergosta-7,22-dien-3-ol Contribute to the Apoptotic Effect and Cell Cycle Arrest of an Extract from Marthasterias glacialis L. in Neuroblastoma Cells
  58. Amino acids, fatty acids and sterols profile of some marine organisms from Portuguese waters
  59. Lessons from the Sea
  60. Phenolic Compounds in Catharanthus roseus
  61. A gas chromatography–mass spectrometry multi-target method for the simultaneous analysis of three classes of metabolites in marine organisms
  62. Further Insights on the Carotenoid Profile of the Echinoderm Marthasterias glacialis L.
  63. Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
  64. Editorial [Hot Topic: The Era of -Omics (Guest Editor: David M. Pereira)]
  65. Metabolomic Analysis of Natural Products
  66. Anti-Proliferative Activity of Meroditerpenoids Isolated from the Brown Alga Stypopodium flabelliforme against Several Cancer Cell Lines
  67. Identification of phenolic compounds in isolated vacuoles of the medicinal plant Catharanthus roseus and their interaction with vacuolar class III peroxidase: an H2O2 affair?
  68. Brassica Seeds
  69. Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission
  70. Exploiting Catharanthus roseus roots: Source of antioxidants
  71. HPLC-PAD-atmospheric pressure chemical ionization-MS metabolite profiling of cytotoxic carotenoids from the echinoderm Marthasterias glacialis (spiny sea-star)
  72. Headspace solid-phase microextraction and gas chromatography/ion trap-mass spectrometry applied to a living system: Pieris brassicae fed with kale
  73. Tomato (Lycopersicon esculentum) Seeds: New Flavonols and Cytotoxic Effect
  74. First report of non-coloured flavonoids inEchium plantagineumbee pollen: differentiation of isomers by liquid chromatography/ion trap mass spectrometry
  75. Simple and reproducible HPLC–DAD–ESI-MS/MS analysis of alkaloids in Catharanthus roseus roots
  76. Erratum to “Metabolic fate of dietary volatile compounds in Pieris brassicae” [Microchemical Journal 93 (2009) 99–109]
  77. Phenolics Metabolism in Insects: Pieris brassicae − Brassica oleracea var. costata Ecological Duo
  78. Metabolic fate of dietary volatile compounds in Pieris brassicae
  79. Boerhaavia diffusa: Metabolite profiling of a medicinal plant from Nyctaginaceae
  80. Phenolics: From Chemistry to Biology
  81. Targeted metabolite analysis of Catharanthus roseus and its biological potential
  82. Volatile composition of Catharanthus roseus (L.) G. Don using solid-phase microextraction and gas chromatography/mass spectrometry
  83. Brassica oleracea var. costata : comparative study on organic acids and biomass production with other cabbage varieties
  84. Pieris brassicae Inhibits Xanthine Oxidase
  85. Screening of Antioxidant Phenolic Compounds Produced by In Vitro Shoots of Brassica oleracea L. var. costata DC
  86. In Vitro Cultures of Brassica oleracea L. var. costata DC: Potential Plant Bioreactor for Antioxidant Phenolic Compounds
  87. Targeted Metabolite Analysis and Biological Activity of Pieris brassicae Fed with Brassica rapa var. rapa
  88. New Phenolic Compounds and Antioxidant Potential of Catharanthus roseus
  89. Recent Trends in High Throughput Analysis and Antioxidant Potential Screening for Phenolics
  90. Free Amino Acids of Tronchuda Cabbage (Brassica oleracea L. Var. costata DC): Influence of Leaf Position (Internal or External) and Collection Time
  91. Multivariate Analysis of Tronchuda Cabbage (Brassica oleracea L. var. costata DC) Phenolics: Influence of Fertilizers
  92. Screening of Antioxidant Compounds During Sprouting of Brassica oleracea L. var. costata DC